Janux Therapeutics Inc
JANX
$18.15-1.31%
End of day · as of Oct 13, 2026, 4:45 AM ET
Mkt cap
$1.49B
EV/Sales
143.6
P/E ratio
N/A
FY2025 Revenue
$10.00M
EPS (TTM)
$-1.64
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-1136.25%
Beta
2.96
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported JANX revenue for 2025-12-31 was $10.0M. Net income was -$113.6M. Revenue was down 5.6% from 2024-12-31 to 2025-12-31. JANX currently screens at market cap $1.49B.
Use this JANX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full JANX income, balance, and cash tables.
Janux Therapeutics Inc (JANX) is a biotechnology company in the Healthcare sector.
Latest cached Janux Therapeutics Inc (JANX) revenue for Dec 31, 2025 was $10.0M. Net income was -$113.6M. Statements: https://lician.com/financials/janx
Janux Therapeutics Inc (JANX) market capitalization is $1.49B on the latest cached snapshot.
Janux Therapeutics Inc (JANX) cached previous close $18.39; day range $18.15 – $18.52; volume 802,478. Session quote: https://lician.com/quote/janx
Janux Therapeutics Inc (JANX) latest cached earnings event is "JANX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings